Sepsis Syndrome. Sepsis, unspecified
Conditions
Interventions
Intervention 1: Single dose group: Patients in this group will receive intravenous gentamicin 1.7 mg/kg in a single dose daily for an unspecified period of time which is depended on their septic condi
Treatment - Drugs
Single dose group: Patients in this group will receive intravenous gentamicin 1.7 mg/kg in a single dose daily for an unspecified period of time which is depended on their septic condition.
Divided dose group: Patients in this group will receive intravenous gentamicin 1.7 mg/kg/dose in two or three doses per day for an unspecified period of time which is depended on their septic conditio
Sponsors
Vice Chancellor for Research of Tabriz University of Medical Science
Eligibility
Sex/Gender
All
Age
12 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (to be 12 to 55 years old; to have a normal renal function; to have septic syndrome without any underlying conditions) Exclusion criteria: (to have a positive blood culture with resistance to gentamicin)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood urea nitrogen level. Timepoint: at the treatment initiation and seven days after the initiation of the treatment. Method of measurement: Biochemistry laboratorial blood test.;Blood creatinine level. Timepoint: at the treatment initiation and seven days after the initiation of the treatment. Method of measurement: Biochemistry laboratorial blood test.;Audiometry. Timepoint: at the treatment initiation and seven days after the initiation of the treatment. Method of measurement: Using an audiometry device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Parviz Saleh
Tabriz University of Medical Sciences
Outcome results
None listed